Repurposing antimicrobials with ultrasound-triggered nanoscale systems for targeted biofilm drug delivery.
Ontology highlight
ABSTRACT: Chronic infections represent a major clinical challenge due to the enhanced antimicrobial tolerance of biofilm-dwelling bacteria. To address this challenge, an ultrasound-responsive nanoscale drug delivery platform (nanodroplets) is presented in this work, loaded with four different antimicrobial agents, capable of simultaneous biofilm disruption and targeted antimicrobial delivery. When loaded, a robust protective effect against clinically-derived MRSA and ESBL Gram-positive and Gram-negative planktonic isolates was shown in vitro. Upon application of therapeutic ultrasound, an average 7.6-fold, 44.4-fold, and 25.5-fold reduction was observed in the antibiotic concentrations compared to free drug required to reach the MBC, MBEC and complete persister eradication levels, respectively. Nano
SUBMITTER: Choi V
PROVIDER: S-EPMC11962098 | biostudies-literature | 2025 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA